HoLEP Vs BipolEP in Management of BPH Patients with Large Prostates

Launched by ASSIUT UNIVERSITY · Jan 3, 2025

Keywords

ClinConnect Summary

Benign prostatic hyperplasia (BPH) is a prevalent condition among older men. It is characterized by non-cancerous enlargement of the prostate gland often leading to urinary obstruction and significant morbidity. In case of failure of medical treatment, surgical intervention is often required especially in patients with larger prostates. Surgical options in such cases include Holmium Laser Enucleation of the Prostate (HoLEP) and Bipolar Enucleation of the Prostate (BipolEP). These modalities have emerged as promising relatively minimally invasive treatment options in patients with large pros...

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Age \>50 years
• • Prostate volume \>80 ml
• • Failure of or noncompliance with medical treatment
• • IPSS \>15
• • Qmax \<15 ml/sec
• • Urinary retention and fixed catheters with poor results on trial of voiding without catheter
• Exclusion Criteria:
• • Patients with active UTI
• • Prostate cancer
• • Bladder carcinoma
• • Urethral stricture
• • Neurogenic bladder disorders
• • Redo cases

Trial Officials